What agents can you combine with a TKI to improve progression-free survival in EGFR-mutant lung cancer? Dr Mark Kris discusses recent data from ASCO on this topic.
Medscape Oncology
Original Article: 'An Inconvenient Truth': Add Bev or Chemo to TKIs in Lung Cancer